Key Points
- Intuitive Surgical EVP Gary Loeb sold 400 shares at an average price of $379, generating $151,600. The transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced his holdings by 6.99% to 5,320 shares.
- ISRG opened at $393.38, near its 50-day moving average of $392.49 and below its 200-day average of $444.21. The stock has traded between $328.57 and $603.88 over the past year.
- The company recently exceeded quarterly expectations, reporting $2.80 EPS and $2.89 billion in revenue, up 18.4% year over year. Analysts maintain a “Moderate Buy” consensus with an average price target of $509.02.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Gary Loeb sold 400 shares of the company's stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares of the company's stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Gary Loeb also recently made the following trade(s):
- On Wednesday, June 10th, Gary Loeb sold 400 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00.
Intuitive Surgical Stock Performance
ISRG stock opened at $393.38 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a market capitalization of $138.97 billion, a price-to-earnings ratio of 45.06, a price-to-earnings-growth ratio of 2.74 and a beta of 1.47. The business's 50 day moving average price is $392.49 and its two-hundred day moving average price is $444.21.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm's quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.81 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.
Analysts Set New Price Targets
Several research firms recently commented on ISRG. Citigroup dropped their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. Stifel Nicolaus reduced their price objective on Intuitive Surgical from $670.00 to $550.00 and set a "buy" rating for the company in a research report on Friday, July 17th. BMO Capital Markets reiterated an "outperform" rating on shares of Intuitive Surgical in a research note on Monday, July 20th. BTIG Research dropped their target price on Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating on the stock in a report on Friday, July 17th. Finally, Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an "overweight" rating in a research note on Thursday, April 23rd. Twenty research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $509.02.
Check Out Our Latest Research Report on Intuitive Surgical
Institutional Trading of Intuitive Surgical
A number of institutional investors have recently made changes to their positions in ISRG. State Street Corp raised its holdings in shares of Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider's stock valued at $8,892,753,000 after purchasing an additional 162,264 shares during the last quarter. Capital World Investors boosted its holdings in Intuitive Surgical by 1.7% in the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider's stock worth $4,449,491,000 after purchasing an additional 127,526 shares during the last quarter. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $2,856,987,000. Invesco Ltd. raised its stake in Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider's stock valued at $2,338,350,000 after buying an additional 611,268 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after buying an additional 116,292 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
